Top compounds associated with response to NMRK2


Feature Type Standardized
Nominal ANOVA
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.075 0.04
mRNA lapatinib CCLE pan-cancer AAC 0.088 0.04
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 0.04
mRNA MG-132 GDSC1000 pan-cancer AAC -0.11 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.04
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.072 0.05
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.066 0.05
mRNA PLX4720 CCLE pan-cancer AAC 0.083 0.05
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.07 0.05
mRNA Erlotinib FIMM pan-cancer AAC 0.32 0.05
Download CSV